• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用模式生物进行衰老研究的药物再利用。

Drug repurposing for aging research using model organisms.

机构信息

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), The Genome Campus, Hinxton, Cambridge, CB10 1SD, UK.

Department of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, Gower Street, London, WC1E 6BT, UK.

出版信息

Aging Cell. 2017 Oct;16(5):1006-1015. doi: 10.1111/acel.12626. Epub 2017 Jun 16.

DOI:10.1111/acel.12626
PMID:28620943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5595691/
Abstract

Many increasingly prevalent diseases share a common risk factor: age. However, little is known about pharmaceutical interventions against aging, despite many genes and pathways shown to be important in the aging process and numerous studies demonstrating that genetic interventions can lead to a healthier aging phenotype. An important challenge is to assess the potential to repurpose existing drugs for initial testing on model organisms, where such experiments are possible. To this end, we present a new approach to rank drug-like compounds with known mammalian targets according to their likelihood to modulate aging in the invertebrates Caenorhabditis elegans and Drosophila. Our approach combines information on genetic effects on aging, orthology relationships and sequence conservation, 3D protein structures, drug binding and bioavailability. Overall, we rank 743 different drug-like compounds for their likelihood to modulate aging. We provide various lines of evidence for the successful enrichment of our ranking for compounds modulating aging, despite sparse public data suitable for validation. The top ranked compounds are thus prime candidates for in vivo testing of their effects on lifespan in C. elegans or Drosophila. As such, these compounds are promising as research tools and ultimately a step towards identifying drugs for a healthier human aging.

摘要

许多日益流行的疾病都有一个共同的风险因素

年龄。然而,尽管许多基因和途径被证明在衰老过程中很重要,而且许多研究表明遗传干预可以导致更健康的衰老表型,但针对衰老的药物干预措施却知之甚少。一个重要的挑战是评估将现有药物重新用于模型生物初步测试的潜力,在这些实验中是可能的。为此,我们提出了一种新方法,根据已知哺乳动物靶点的药物样化合物在秀丽隐杆线虫和果蝇中调节衰老的可能性对其进行排序。我们的方法结合了关于衰老的遗传效应、同源关系和序列保守性、3D 蛋白质结构、药物结合和生物利用度的信息。总的来说,我们根据药物样化合物调节衰老的可能性对 743 种不同的化合物进行了排序。尽管可用的验证性公共数据稀疏,但我们的排名成功地富集了许多用于调节衰老的化合物的证据。因此,排名靠前的化合物是在秀丽隐杆线虫或果蝇中测试其对寿命影响的体内试验的首选候选物。因此,这些化合物作为研究工具很有前景,最终可能会发现有助于人类健康衰老的药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3fd/5595691/2af42addaf11/ACEL-16-1006-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3fd/5595691/f9bd00d84bbc/ACEL-16-1006-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3fd/5595691/e023926881cd/ACEL-16-1006-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3fd/5595691/43a43f6dd0e9/ACEL-16-1006-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3fd/5595691/e2a4ce37e5b8/ACEL-16-1006-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3fd/5595691/2af42addaf11/ACEL-16-1006-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3fd/5595691/f9bd00d84bbc/ACEL-16-1006-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3fd/5595691/e023926881cd/ACEL-16-1006-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3fd/5595691/43a43f6dd0e9/ACEL-16-1006-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3fd/5595691/e2a4ce37e5b8/ACEL-16-1006-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3fd/5595691/2af42addaf11/ACEL-16-1006-g005.jpg

相似文献

1
Drug repurposing for aging research using model organisms.利用模式生物进行衰老研究的药物再利用。
Aging Cell. 2017 Oct;16(5):1006-1015. doi: 10.1111/acel.12626. Epub 2017 Jun 16.
2
The DrugAge database of aging-related drugs.与衰老相关药物的DrugAge数据库。
Aging Cell. 2017 Jun;16(3):594-597. doi: 10.1111/acel.12585. Epub 2017 Mar 16.
3
Cell non-autonomous regulation of health and longevity.细胞非自主调控健康与长寿。
Elife. 2020 Dec 10;9:e62659. doi: 10.7554/eLife.62659.
4
Repurposed FDA-approved drugs targeting genes influencing aging can extend lifespan and healthspan in rotifers.经美国食品和药物管理局批准的针对影响衰老的基因的再利用药物,可以延长轮虫的寿命和健康寿命。
Biogerontology. 2018 Apr;19(2):145-157. doi: 10.1007/s10522-018-9745-9. Epub 2018 Jan 16.
5
Systems biology of aging in four species.四种物种衰老的系统生物学
Curr Opin Biotechnol. 2007 Aug;18(4):355-9. doi: 10.1016/j.copbio.2007.07.004. Epub 2007 Aug 2.
6
Nutraceutical interventions for promoting healthy aging in invertebrate models.营养干预促进无脊椎动物模型的健康衰老。
Oxid Med Cell Longev. 2012;2012:718491. doi: 10.1155/2012/718491. Epub 2012 Sep 6.
7
Screening lifespan-extending drugs in Caenorhabditis elegans via label propagation on drug-protein networks.通过药物-蛋白质网络上的标签传播在秀丽隐杆线虫中筛选寿命延长药物。
BMC Syst Biol. 2016 Dec 23;10(Suppl 4):131. doi: 10.1186/s12918-016-0362-4.
8
Repurposing FDA-approved drugs for anti-aging therapies.将美国食品药品监督管理局(FDA)批准的药物用于抗衰老疗法。
Biogerontology. 2016 Nov;17(5-6):907-920. doi: 10.1007/s10522-016-9660-x. Epub 2016 Aug 2.
9
Using the drug-protein interactome to identify anti-ageing compounds for humans.利用药物-蛋白质相互作用组鉴定人类抗衰老化合物。
PLoS Comput Biol. 2019 Jan 9;15(1):e1006639. doi: 10.1371/journal.pcbi.1006639. eCollection 2019 Jan.
10
Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling.基于蛋白配体的药效团:在计算配体剖析中的生成和应用评估。
J Chem Inf Model. 2012 Apr 23;52(4):943-55. doi: 10.1021/ci300083r. Epub 2012 Apr 11.

引用本文的文献

1
Genetic Modulation of Lifespan: Dynamic Effects, Sex Differences, and Body Weight Trade-offs.寿命的基因调控:动态效应、性别差异及体重权衡
bioRxiv. 2025 Jul 21:2025.04.27.649857. doi: 10.1101/2025.04.27.649857.
2
Pharmacogenomic screening identifies and repurposes leucovorin and dyclonine as pro-oligodendrogenic compounds in brain repair.药物基因组筛查鉴定并重新利用亚叶酸和地卡因作为脑修复中的促少突胶质细胞生成化合物。
Nat Commun. 2024 Nov 13;15(1):9837. doi: 10.1038/s41467-024-54003-9.
3
Pharmacology of Aging: as a Tool to Validate Drug Targets for Healthy Lifespan.

本文引用的文献

1
Repurposing FDA-approved drugs for anti-aging therapies.将美国食品药品监督管理局(FDA)批准的药物用于抗衰老疗法。
Biogerontology. 2016 Nov;17(5-6):907-920. doi: 10.1007/s10522-016-9660-x. Epub 2016 Aug 2.
2
Machine-learning scoring functions to improve structure-based binding affinity prediction and virtual screening.用于改进基于结构的结合亲和力预测和虚拟筛选的机器学习评分函数。
Wiley Interdiscip Rev Comput Mol Sci. 2015 Nov-Dec;5(6):405-424. doi: 10.1002/wcms.1225. Epub 2015 Aug 28.
3
A network pharmacology approach reveals new candidate caloric restriction mimetics in C. elegans.
衰老药理学:作为验证健康寿命药物靶点的工具
Aging Biol. 2024 Sep 13;2(1):20240034. doi: 10.59368/agingbio.20240034.
4
Repurposing effect of cardiovascular-metabolic drug to increase lifespan: a systematic review of animal studies and current clinical trial progress.心血管代谢药物用于延长寿命的新用途效应:动物研究及当前临床试验进展的系统评价
Front Pharmacol. 2024 Jun 20;15:1373458. doi: 10.3389/fphar.2024.1373458. eCollection 2024.
5
Inactive-enriched machine-learning models exploiting patent data improve structure-based virtual screening for PDL1 dimerizers.利用专利数据的非活性增强型机器学习模型改进了基于结构的PDL1二聚体虚拟筛选。
J Adv Res. 2025 Jan;67:185-196. doi: 10.1016/j.jare.2024.01.024. Epub 2024 Jan 26.
6
Abl depletion via autophagy mediates the beneficial effects of quercetin against Alzheimer pathology across species.通过自噬介导的Abl缺失介导了槲皮素对跨物种阿尔茨海默病病理的有益作用。
Cell Death Discov. 2023 Oct 14;9(1):376. doi: 10.1038/s41420-023-01592-x.
7
Hydralazine Revives Cellular and Ocular Lens Health-Span by Ameliorating the Aging and Oxidative-Dependent Loss of the Nrf2-Activated Cellular Stress Response.肼屈嗪通过改善Nrf2激活的细胞应激反应中与衰老和氧化相关的丧失来恢复细胞和晶状体的健康寿命。
Antioxidants (Basel). 2023 Jan 6;12(1):140. doi: 10.3390/antiox12010140.
8
Geroscience-guided repurposing of FDA-approved drugs to target aging: A proposed process and prioritization.衰老导向的 FDA 批准药物再利用:一种建议的流程和优先级。
Aging Cell. 2022 Apr;21(4):e13596. doi: 10.1111/acel.13596. Epub 2022 Mar 27.
9
Caenorhabditis elegans for rare disease modeling and drug discovery: strategies and strengths.秀丽隐杆线虫在罕见病建模和药物发现中的应用:策略和优势。
Dis Model Mech. 2021 Aug 1;14(8). doi: 10.1242/dmm.049010. Epub 2021 Aug 9.
10
The neuronal receptor tyrosine kinase Alk is a target for longevity.神经元受体酪氨酸激酶Alk是长寿的一个靶点。
Aging Cell. 2020 May;19(5):e13137. doi: 10.1111/acel.13137. Epub 2020 Apr 15.
一种网络药理学方法揭示了秀丽隐杆线虫中热量限制模拟物的新候选物。
Aging Cell. 2016 Apr;15(2):256-66. doi: 10.1111/acel.12432. Epub 2015 Dec 16.
4
β-Guanidinopropionic acid extends the lifespan of Drosophila melanogaster via an AMP-activated protein kinase-dependent increase in autophagy.β-胍基丙酸通过依赖于AMP激活的蛋白激酶增加自噬来延长黑腹果蝇的寿命。
Aging Cell. 2015 Dec;14(6):1024-33. doi: 10.1111/acel.12371. Epub 2015 Jun 29.
5
Genistein from Vigna angularis Extends Lifespan in Caenorhabditis elegans.豇豆中的染料木黄酮可延长秀丽隐杆线虫的寿命。
Biomol Ther (Seoul). 2015 Jan;23(1):77-83. doi: 10.4062/biomolther.2014.075. Epub 2015 Jan 1.
6
Database resources of the National Center for Biotechnology Information.美国国立生物技术信息中心的数据库资源。
Nucleic Acids Res. 2015 Jan;43(Database issue):D6-17. doi: 10.1093/nar/gku1130. Epub 2014 Nov 14.
7
Does a more precise chemical description of protein-ligand complexes lead to more accurate prediction of binding affinity?对蛋白质-配体复合物进行更精确的化学描述是否能更准确地预测结合亲和力?
J Chem Inf Model. 2014 Mar 24;54(3):944-55. doi: 10.1021/ci500091r. Epub 2014 Feb 20.
8
Ensembl 2014.Ensembl 2014.
Nucleic Acids Res. 2014 Jan;42(Database issue):D749-55. doi: 10.1093/nar/gkt1196. Epub 2013 Dec 6.
9
Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signaling.道斯莫芬通过抑制骨形态发生蛋白信号转导逆转乳腺癌起始细胞的间充质表型。
Cell Signal. 2014 Feb;26(2):352-62. doi: 10.1016/j.cellsig.2013.11.022. Epub 2013 Nov 23.
10
Gene3D: Multi-domain annotations for protein sequence and comparative genome analysis.Gene3D:用于蛋白质序列和比较基因组分析的多功能域注释。
Nucleic Acids Res. 2014 Jan;42(Database issue):D240-5. doi: 10.1093/nar/gkt1205. Epub 2013 Nov 21.